Hexyon

Hexavalent vaccine (DTP-HBV-Hib-IPV) · Sanofi Winthrop Industrie

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Hexyon, covering 2025-09-29 to 2026-08-07. Get the full timeline:

Most recent: EMA Authorised: Hexyon (filamentous haemagglutinin;Haemophilus influenzae type B polysaccharide (polyribosylribitol phosphate);hepatitis B surface antigen;pertussis toxoid;poliovirus (inactivated) type 1 (Mahoney strain) produced on Vero cells;poliovirus (inactivated) type 2 (MEF-1 strain) produced on Vero cells;poliovirus (inactivated) type 3 (Saukett strain) produced on Vero cells;tetanus protein;tetanus toxoid adsorbed on aluminium hydroxide, hydrated;Diphtheria toxoid) — Sanofi Winthrop Industrie

See pricing